FindTrial
Sign In

A CLINICAL TRIAL TO STUDY THE EVALUATION OF CHANGE IN QUALITY OF LIFE IN PATIENTS WITH SOLID TUMORS UNDERGOING CHEMOTHERAPY-BY GUIDELINES BASED SELF MANAGEMENT OF SIDE EFFECTS

A RANDOMIZED CONTROLLED STUDY FOR THE EVALUATION OF CHANGE IN QUALITY OF LIFE IN PATIENTS WITH SOLID TUMORS UNDERGOING CHEMOTHERAPY-BY GUIDELINES BASED SELF MANAGEMENT OF SIDE EFFECTS

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2010/091/000232
Enrollment
86
Registered
2010-03-26
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: STANDARD GUIDELINES WITH PATIENT COUNCILING: STANDARD GUIDELINES WITH PATIENT COUNCILING Control Intervention1: NORMAL PROCEDURE: NORMAL PROCEDURE

Sponsors

NIL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1,. All solid tumour patients 2. Be ≥18 years of age or older 3. Naïve in Chemotherapy 4. Be capable of speaking and reading English/Malayalam 5. The patients using Chemotherapy alone 6. Using same regimen throughout in the evaluation period

Exclusion criteria

Exclusion criteria: 1. Mentally retarded patients. 2. Patients having AIDS 3. Patients who are not willing to participate in the study.

Design outcomes

Primary

MeasureTime frame
FIND OUT WHETHER ANY SIGNIFICANT IMPROVEMENTS IN QUALITY OF LIFE IN PATIENTS WHO ARE RECEIVING THE STANDARD GUIDELINES WITH THE CONTROL GROUP WHO ARE NOT RECEIVING THE STANDARD GUIDELINESTimepoint: 0-BASELINE,1-AFTER THE FIRST CHEMOTHERAPY,2-AFTER THE SECOND CHEMOTHERAPY,3-AFTER THE THIRD CHEMOTHERAPY—

Secondary

MeasureTime frame
NILTimepoint: NIL—

Countries

India

Contacts

Public ContactSHIJU.A
shijupharma@gmail.com+91-9809862038

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026